ExactScience vs Synthace
Side-by-side comparison · Updated May 2026
| Description | Exact Sciences Corp. is a leading molecular diagnostics company focused on transforming cancer care through prevention, early detection, and treatment guidance. Their cutting-edge product portfolio includes non-invasive screening tests like Cologuard® for colorectal cancer, Oncotype DX® for predicting cancer recurrence, and OncoExTra® for genomic profiling. The company also offers Riskguard™ for hereditary cancer risk assessment and is pioneering multi-cancer early detection tests. Committed to innovation and scientific validation, Exact Sciences plays a pivotal role in cancer diagnostics, earning endorsements from clinical guidelines and continuous certification as a Great Place to Work®. | Synthace provides a powerful platform designed for optimizing and automating complex biological experiments and processes. Their offerings include applications like Design of Experiments (DOE) for various developmental stages including assay, media, and purification process development, as well as tools for molecular biology such as DNA assembly, and assays like qPCR and ELISA. The company also provides robust resources like blogs, case studies, training courses, and newsletters to support users. |
| Category | Healthcare | Healthcare |
| Rating | No reviews | No reviews |
| Pricing | Free | Pricing unavailable |
| Starting Price | Free | N/A |
| Plans |
| — |
| Use Cases |
|
|
| Tags | molecular diagnosticscancer carepreventionearly detectiontreatment guidance | Design of ExperimentsDOEassay developmentmedia developmentpurification process |
| Features | ||
| Comprehensive suite of cancer tests across the care continuum, including early detection and screening. | ||
| Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening. | ||
| Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment. | ||
| Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection. | ||
| Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits. | ||
| OncoExTra® test for aiding late-stage cancer therapy selection. | ||
| Supports patient and provider through logins for test ordering and results tracking. | ||
| Backed by extensive scientific research, publications, and clinical studies. | ||
| Engages in community outreach and health equity initiatives. | ||
| Design of Experiments (DOE) for assay and media optimization | ||
| Automated qPCR and ELISA assays | ||
| Tools for DNA assembly | ||
| Purification process development | ||
| Comprehensive training courses | ||
| Extensive resources including blogs, case studies, and newsletters | ||
| Cookie consent management | ||
| Request a demo feature | ||
| Privacy policy disclosures | ||
| User-friendly navigation | ||
| View ExactScience | View Synthace | |
Modify This Comparison
Also Compare
Explore more head-to-head comparisons with ExactScience and Synthace.